These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 9118585)

  • 1. Pharmacokinetic changes in the elderly. Do they contribute to drug abuse and dependence?
    Ozdemir V; Fourie J; Busto U; Naranjo CA
    Clin Pharmacokinet; 1996 Nov; 31(5):372-85. PubMed ID: 9118585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo comparisons of constitutive cytochrome P450 3A activity assessed by alprazolam, triazolam, and midazolam.
    Masica AL; Mayo G; Wilkinson GR
    Clin Pharmacol Ther; 2004 Oct; 76(4):341-9. PubMed ID: 15470333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of cytochrome P450 2D6 modifies codeine abuse liability.
    Kathiramalainathan K; Kaplan HL; Romach MK; Busto UE; Li NY; Säwe J; Tyndale RF; Sellers EM
    J Clin Psychopharmacol; 2000 Aug; 20(4):435-44. PubMed ID: 10917405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benzodiazepines and the elderly. A review of potential problems.
    Closser MH
    J Subst Abuse Treat; 1991; 8(1-2):35-41. PubMed ID: 1675691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current benzodiazepine issues.
    Woods JH; Winger G
    Psychopharmacology (Berl); 1995 Mar; 118(2):107-15; discussion 118, 120-1. PubMed ID: 7617794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical pharmacokinetics of anxiolytics and hypnotics in the elderly. Therapeutic considerations (Part I).
    Greenblatt DJ; Harmatz JS; Shader RI
    Clin Pharmacokinet; 1991 Sep; 21(3):165-77. PubMed ID: 1684924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic and pharmacodynamic consequences of metabolism-based drug interactions with alprazolam, midazolam, and triazolam.
    Yuan R; Flockhart DA; Balian JD
    J Clin Pharmacol; 1999 Nov; 39(11):1109-25. PubMed ID: 10579141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alprazolam and benzodiazepine dependence.
    Sellers EM; Ciraulo DA; DuPont RL; Griffiths RR; Kosten TR; Romach MK; Woody GE
    J Clin Psychiatry; 1993 Oct; 54 Suppl():64-75; discussion 76-7. PubMed ID: 8262891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guidelines for the clinical use of benzodiazepines: pharmacokinetics, dependency, rebound and withdrawal. Canadian Society for Clinical Pharmacology.
    Nelson J; Chouinard G
    Can J Clin Pharmacol; 1999; 6(2):69-83. PubMed ID: 10519733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of benzodiazepines in the geriatric population.
    Madhusoodanan S; Bogunovic OJ
    Expert Opin Drug Saf; 2004 Sep; 3(5):485-93. PubMed ID: 15335303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of codeine dependence with inhibitors of cytochrome P450 2D6.
    Fernandes LC; Kilicarslan T; Kaplan HL; Tyndale RF; Sellers EM; Romach MK
    J Clin Psychopharmacol; 2002 Jun; 22(3):326-9. PubMed ID: 12006904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychotropic medications and cytochrome P450 2D6: pharmacokinetic considerations in the elderly.
    Shulman RW; Ozdemir V
    Can J Psychiatry; 1997 Jun; 42 Suppl 1():4S-9S. PubMed ID: 9220124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Abuse of alcohol and benzodiazepine during substitution therapy in heroin addicts: a review of the literature].
    Laqueille X; Launay C; Dervaux A; Kanit M
    Encephale; 2009 Jun; 35(3):220-5. PubMed ID: 19540407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic and pharmacodynamic principles of illicit drug use and treatment of illicit drug users.
    Quinn DI; Wodak A; Day RO
    Clin Pharmacokinet; 1997 Nov; 33(5):344-400. PubMed ID: 9391747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic drug interactions between clobazam and drugs metabolized by cytochrome P450 isoenzymes.
    Walzer M; Bekersky I; Blum RA; Tolbert D
    Pharmacotherapy; 2012 Apr; 32(4):340-53. PubMed ID: 22422635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Substance abuse in older adults].
    Bitar R; Dürsteler KM; Rösner S; Grosshans M; Herdener M; Mutschler J
    Praxis (Bern 1994); 2014 Sep; 103(18):1071-9. PubMed ID: 25183616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Benzodiazepines and forensic aspects].
    Michel L; Lang JP
    Encephale; 2003; 29(6):479-85. PubMed ID: 15029082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytochrome P450 2D6 and treatment of codeine dependence.
    Romach MK; Otton SV; Somer G; Tyndale RF; Sellers EM
    J Clin Psychopharmacol; 2000 Feb; 20(1):43-5. PubMed ID: 10653207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Addictive behaviors and benzodiazepines: 1. Abuse liability and physical dependence.
    Senay EC
    Adv Alcohol Subst Abuse; 1989; 8(1):107-24. PubMed ID: 2565664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.